In resistant plants, pathogen attack often leads to rapid activation of defense responses that limit multiplication and spread of the pathogen. To investigate the signaling mechanisms underlying this process, we carried out a screen for mutants in the signaling pathway governing resistance in Arabidopsis thaliana to the bacterial pathogen Pseudomonas syringae. This involved screening for suppressor mutations that restored resistance to a susceptible line carrying a mutation in the RPS2 resistance gene. A mutant that conferred resistance by activating defense responses in the absence of pathogens was isolated. This mutant, which carries a mutation at the CPR5 locus and was thus designated cpr5-2, exhibited resistance to P. syringae, spontaneous development of necrotic lesions, elevated PR gene expression in the absence of pathogens, and abnormal trichomes. Resistance gene-mediated defenses, including the hypersensitive response, restriction of pathogen growth, and induction of defense-related gene expression, were functional in cpr5-2 mutant plants. Additionally, in cpr5-2 plants RPS2-mediated induction of PR-1 expression was enhanced, whereas RPM1-mediated induction of ELI3 was not. These findings suggest that CPR5 encodes a negative regulator of the RPS2 signal transduction pathway.
In resistant plants, pathogen attack often leads to rapid activation of defense responses that limit multiplication and spread of the pathogen. To investigate the signaling mechanisms underlying this process, we carried out a screen for mutants in the signaling pathway governing resistance in Arabidopsis thaliana to the bacterial pathogen Pseudomonas syringae. This involved screening for suppressor mutations that restored resistance to a susceptible line carrying a mutation in the RPS2 resistance gene. A mutant that conferred resistance by activating defense responses in the absence of pathogens was isolated. This mutant, which carries a mutation at the CPR5 locus and was thus designated cpr5-2, exhibited resistance to P. syringae, spontaneous development of necrotic lesions, elevated PR gene expression in the absence of pathogens, and abnormal trichomes. Resistance gene-mediated defenses, including the hypersensitive response, restriction of pathogen growth, and induction of defense-related gene expression, were functional in cpr5-2 mutant plants. Additionally, in cpr5-2 plants RPS2-mediated induction of PR-1 expression was enhanced, whereas RPM1-mediated induction of ELI3 was not. These findings suggest that CPR5 encodes a negative regulator of the RPS2 signal transduction pathway.
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Disease resistance in plants is often triggered by specific recognition of the invading pathogen. Pathogen recognition results in the rapid activation of a complex series of plant defense responses that limit multiplication and spread of the pathogen within the plant, thus leading to resistance. Common defense responses include the production of reactive oxygen species, the hypersensitive response (HR), which is characterized by rapid cell death and tissue necrosis at the site of infection, and the production of antimicrobial compounds (phytoalexins) and lytic enzymes (reviewed in HammondKosack and Jones 1996; Baker et al. 1997; Greenberg 1997) .
Many of these induced responses are controlled, at least in part, by transcriptional activation of defense-related genes, including the pathogenesis-related (PR) genes (Lamb et al. 1989; Baker et al. 1997) .
Pathogen recognition is governed by genes in both the plant and the pathogen (Keen 1990) . Plant disease resistance genes confer on the plant the ability to recognize pathogens expressing specific recognition determinants. Production of these pathogen determinants is, in turn, controlled by specific pathogen avirulence (avr) genes. The prevailing hypothesis is that the recognition event mediated by matching resistance and avr genes triggers a signal transduction pathway that culminates in the activation of plant defense responses. The molecular isolation of several disease resistance genes has revealed that the majority cloned to date appear to encode components of signal transduction pathways (Bent 1996; Hammond-Kosack and Jones 1997) . For example, the RPS2 gene of Arabidopsis thaliana, which confers resistance to strains of the bacterial pathogen Pseudomonas syringae expressing avrRpt2 Yu et al. 1993) , encodes a protein containing several motifs suggestive of a role in signaling, including a leucine-rich repeat (LRR) domain and a nucleotide-binding site (Bent et al. 1994; Mindrinos et al. 1994) . However, the actual mechanisms by which RPS2 and other resistance genes mediate resistance are not clear. A current area of intense research is focused on further elucidating the regulatory mechanisms governing resistance by identifying and characterizing additional components of disease resistance signal transduction pathways.
A number of genetic approaches have been used to further dissect disease resistance signaling pathways (reviewed in Dangl et al. 1996; Kunkel 1996; Ryals et al. 1996; Delaney 1997) . These include screens for mutants that exhibit enhanced disease susceptibility (eds mutants; Glazebrook et al. 1996; Rogers and Ausubel 1997) , mutants that have lost genotype-specific resistance to avirulent pathogens (ndr1 and eds1; Century et al. 1995; Parker et al. 1996) , mutants that either don't induce (npr1, niml; Cao et al. 1994; Delaney et al. 1995) or inappropriately regulate defense-related gene expression (cpr, cim mutants; Lawton et al. 1993; Bowling et al. 1994 Bowling et al. , 1997 , and mutants that form HR-like necrotic lesions in the absence of pathogen infection (acd2 and lsd mutants; Dietrich et al. 1994; Greenberg et al. 1994; Weyman et al. 1995) . The acd2, lsd, and cpr5 mutants are examples of a mutant class known as "disease lesion mimics" that behave as if they were under constant pathogen attack. These mutants often exhibit elevated levels of salicylic acid (SA), defenserelated gene expression in the absence of pathogens or SAinducing compounds, and enhanced resistance to a number of bacterial and fungal pathogens. It is likely that these mutants define genes encoding signaling components regulating the induction or containment of HR-related cell death in response to pathogen attack Ryals et al. 1996; Delaney 1997) .
It is not yet clear whether resistance signaling pathways interact with other signal transduction processes in plants. The isolation of several A. thaliana mutants with pleiotropic phenotypes such as ttg, which affects both trichome development and anthocyanin production (Marks 1997) , and several cop and det mutants that affect photomorphogenesis and the regulation of defense gene expression (Mayer et al. 1996) , provides evidence for cross-talk between signaling pathways governing seemingly unrelated processes. As disease resistance signal transduction pathways become better understood, interactions between the signaling pathways governing pathogen defense and other processes, including development, may be revealed.
We have used a complementary genetic approach to dissect the signal transduction pathway coupling pathogen recognition to expression of disease resistance in A. thaliana. This involved screening for mutants that restore resistance to an rps2 mutant line that is susceptible to P. syringae strains expressing avrRpt2 . Our expectation was that this screen would identify mutants that restore RPS2-dependent resistance as well as mutants that bypass the requirement for pathogen recognition. One of the suppressors isolated in this screen carries a mutation at the CPR5 locus (Bowling et al. 1997) , and was thus designated cpr5-2. This mutant exhibits an intriguing combination of phenotypes, including enhanced resistance to P. syringae, spontaneous development of necrotic lesions in uninoculated plants, and abnormal trichomes. We show that disease resistance mediated by the RPS2, RPS5, and RPM1 genes is functional in the cpr5-2 mutant background and that cpr5-2 specifically enhances the induction of PR-1 gene expression triggered by RPS2-mediated pathogen recognition.
RESULTS

Isolation of mutations that suppress the disease-susceptible phenotype of rps2 mutant plants.
We carried out a screen for A. thaliana mutants that suppress the disease-susceptible phenotype of an rps2 mutant in order to identify additional genes important for resistance to the bacterial pathogen P. syringae. To facilitate isolation of components of the RPS2-mediated recognition pathway we screened for mutants with enhanced resistance after inoculation with a P. syringae strain expressing the avirulence gene avrRpt2.
As shown in Figure 1 , wild-type A. thaliana ecotype Columbia (Col-0) plants were susceptible to the P. syringae pv. tomato (Pst) strain DC3000 and developed bacterial specklike disease symptoms consisting of many small, individual gray lesions surrounded by a halo of chlorosis. In contrast, Col-0 plants (which possess a functional RPS2 gene; Kunkel et al. 1993) , were resistant to Pst DC3000 expressing the avirulence gene avrRpt2 (Pst DC3000 [avrRpt2]) and thus exhibited no disease symptoms. rps2 mutant plants were susceptible to both Pst DC3000 and Pst DC3000 (avrRpt2). To isolate mutations that suppress the disease-susceptible phenotype of rps2 mutants, populations of M 2 plants derived from seed of rps2 mutant plants that had been mutagenized with ethylmethane sulfonate (EMS) were inoculated with Pst DC3000 (avrRpt2). We screened approximately 17,500 M 2 plants and isolated 28 suppressor mutant lines that exhibited enhanced resistance upon re-testing in the M 3 generation. One of the most resistant of these suppressor mutants, cpr5-2, was chosen for further analysis. The remaining 27 suppressor lines are currently being characterized, and will be described in more detail elsewhere (G. Kalinowski, A. Kloek, M. Verbsky, and B. Kunkel, unpublished results).
cpr5-2 confers full resistance to P. syringae.
In contrast to the parental rps2 line, the cpr5-2 rps2 suppressor mutant line was resistant when inoculated with Pst DC3000 (avrRpt2) (Fig. 1) . To determine whether resistance was restored specifically to Pst DC3000 (avrRpt2), we tested cpr5-2 rps2 for resistance to several pathogenic P. syringae strains not expressing avrRpt2, including Pst DC3000, Pst 3455 (Whalen et al. 1991) , and the P. syringae pv. maculicola (Psm) strain m4 (Debener et al. 1991) . cpr5-2 rps2 mutant plants were resistant to all three of these strains ( Fig. 1 ; and data not shown). This indicates that enhanced resistance in cpr5-2 rps2 plants is not specific to strains expressing avrRpt2, suggesting that resistance in this mutant line is independent of avrRpt2-mediated pathogen recognition. Furthermore, these observations suggest that resistance in the cpr5-2 rps2 line is not due to gain of a novel capacity to specifically detect infection by Pst DC3000.
To determine if resistance in cpr5-2 rps2 was associated with restricted growth of P. syringae within the plant, growth of the pathogen in mutant plants was monitored over the course of several days. As shown in Figure 2A , growth of Pst DC3000 (avrRpt2) was limited in cpr5-2 rps2 mutant plants, obtaining a final concentration of only 10 4 to 10 5 CFU/cm 2 . This was in marked contrast to the high levels of bacterial growth observed in CPR5 rps2 plants, where the same strain reached a final concentration of 10 6 to 10 7 CFU/cm 2 ( Fig. 2A ). The 50-to 100-fold reduction of bacterial growth observed in cpr5-2 rps2 plants was similar to the limitation of growth observed in wild-type Col-0 plants, where restriction of the pathogen was a result of resistance gene-mediated pathogen recognition ( Fig. 2A) . Pst DC3000, which grew to high levels in wild-type Col-0 plants, was similarly restricted in cpr5-2 rps2 mutant plants (Fig. 2B ).
cpr5-2 plants develop spontaneous lesions prior to infection.
The cpr5-2 rps2 mutant was initially isolated based on its enhanced resistance to Pst DC3000. Upon closer inspection we observed that uninoculated cpr5-2 rps2 plants developed macroscopic, localized, yellow or brown necrotic lesions, reminiscent of those observed during an HR. Lesion formation in cpr5-2 mutant plants was, at least in part, developmentally regulated, as tissue necrosis initially appeared on cotyledons of 2-to 3-week-old seedlings, followed by chlorosis and grad-ual necrosis of the entire cotyledon. As shown in Figure 3 , as the mutant plants matured, chlorotic and necrotic lesions became apparent on the older leaves. Necrosis often started at the base of the midrib, and then extended into the leaf (Fig.  3B) . Development of this lesion-mimic phenotype was independent of pathogen attack, as lesion development also occurred on seedlings grown in axenic culture (data not shown).
We noted variation in lesion development from experiment to experiment, but this variability was not strongly dependent on day length or light intensity (data not shown). However, high humidity appeared to delay the formation of macroscopic lesions. Visible tissue necrosis was not evident until 3 to 4 weeks after germination in seedlings grown under the very humid conditions present in axenic culture (data not shown). cpr5-2 rps2 mutant plants were also somewhat smaller than their CPR5 rps2 progenitor or their wild-type siblings. The reduction in plant size, which was reflected both in overall stature of the plant (data not shown) and in leaf size (Fig. 3B) , was evident both in seedlings grown under axenic conditions and in those grown in soil.
cpr5-2 mutants have abnormal trichomes.
A third phenotype of cpr5-2 rps2 mutant plants was abnormal trichomes. As illustrated in Figure 4 , trichomes on the leaves of cpr5-2 mutants were much smaller than trichomes present on wild-type plants. In addition, the majority of cpr5-2 trichomes had only two branches, while wild-type trichomes typically had three or four ( Fig. 4 ; Hülskamp et al. 1994; Marks 1997 ). However, the spacing and number of trichomes per leaf appeared to be unaltered. The mutant trichomes also had a transparent, "glassy" appearance, and lacked the calcium-containing papillae found in the mature secondary cell wall of wild-type trichomes (data not shown; Marks 1997). Additional phenotypes often associated with trichome mutations, such as alterations in production of seed coat mucilage and root hair development, appeared to be normal in cpr5-2 mutant plants (data not shown).
Genetic analysis of cpr5-2.
To determine the genetic basis of the disease resistance, lesion-mimic, and abnormal trichome phenotypes in the cpr5-2 rps2 mutant line, we crossed the mutant to both CPR5 rps2 plants and wild-type Col-0, which carries a functional RPS2 gene. As is summarized in Table 1 , the F 1 progeny from both Six-week-old Arabidopsis thaliana plants were inoculated by vacuum infiltration with the indicated Pst strains and the concentration of bacteria in the plant leaves assayed after 0, 2, and 4 days. A, Growth of Pst DC3000 (avrRpt2) in the indicated A. thaliana lines, B, Growth of Pst DC3000 and Pst DC3000 (avrRpt2) in Col-0 (CPR5 RPS2) and cpr5-2 RPS2 plants. C, Growth of Pst DC3000, Pst DC3000 (avrRpm1), and Pst DC3000 (avrPphB) in wild-type Col-0 and cpr5-2 plants. Data points represent means of three independent determinations ± SEM. Data presented in A and B are from the same experiment; thus, results for Pst DC3000 (avrRpt2) growth in Col-0 and cpr5-2 RPS2 are presented in both panels for direct comparison. Experiments presented in A and B were repeated a minimum of three times with similar results.
crosses were susceptible to Pst DC3000, indicating that the cpr5-2 mutation is recessive. The F 1 plants were allowed to self-pollinate and the resulting F 2 progeny were assayed to determine the segregation pattern of resistance conferred by the cpr5-2 mutation. In the F 2 progeny from both crosses resistance segregated as a recessive, single-gene trait (Table 1) . The lesion-mimic and abnormal trichome phenotypes cosegregated with resistance in these crosses (Table 1) . Additionally, in 452 cpr5-2 F 2 progeny from a cross between cpr5-2 and Landsberg erecta (La-er), we did not detect any recombinant plants in which the lesion-mimic and trichome phenotypes were separated, indicating that these phenotypes are conferred by a defect at a single locus, or at two very tightly linked loci. The conclusion that all three phenotypes are due to mutation of a single locus is strengthened by the fact that an A. thaliana mutant exhibiting similar lesion-mimic and abnormal trichome development phenotypes was isolated in an independent screen. This mutant, cpr5 (now referred to as cpr5-1), was isolated in a screen for mutants with elevated expression of the BGL2 promoter, and was thus assigned the cpr (constitutive expressor of PR genes) designation (Bowling et al. 1997) . Complementation tests between cpr5-1 and cpr5-2 indicated that the two mutants are allelic (data not shown; Bowling et al. 1997 ).
The abnormal cpr5-2 trichome phenotype most closely resembles that observed for the gl3 trichome mutant. The leaves of gl3 mutant plants also have short, mostly unbranched trichomes (Marks 1997) . Although gl3 mutant plants do not exhibit the lesion-mimic or enhanced resistance phenotypes observed in cpr5-2 (data not shown), it was possible that cpr5-2 was an unusual allele of gl3. To investigate this possibility the cpr5-2 rps2 mutant was crossed to gl3 and the resulting F 1 and F 2 progeny scored for their resistance, lesion-mimic, and trichome phenotypes. The F 1 progeny exhibited wild-type phenotypes for all three traits, indicating that gl3 and cpr5-2 are not allelic. In addition, the random segregation of the resistance and lesion-mimic phenotypes from the gl3 phenotype among the F 2 progeny indicated that the GL3 and CPR5 loci are unlinked (Table 1 ; and data not shown).
To determine the map position of the CPR5 locus we took advantage of the fact that the gl3 mutant used in the complementation test was in the La-er background (Table 1) . F 2 progeny from this cross were used to map cpr5-2 relative to selected molecular markers positioned at intervals of 20 to 40 centiMorgans (cM) on each of the five chromosomes (Konieczny and Ausubel 1993; Bell and Ecker 1994) . As summarized in Table 2 , cpr5-2 mapped to chromosome 5, in an approximately 7 cM interval between the markers g2368 and m555. Although we mapped cpr5-2 to the same region of chromosome 5 reported for cpr5-1 by Bowling et al. (1997) , we place cpr5-2 between g2368 and m555.
Based on complementation tests and map position, cpr5-2 defines a new locus affecting trichome development. Genetic analysis indicates that the cpr5-2 mutation is not an allele of the gl2, gl3, an, try, sti, or zwi loci, which are known to affect trichome development (J. Larkin, unpublished results; Hül-skamp et al. 1994; Oppenheimer et al. 1997) .
Resistance gene-mediated induction of defense responses is functional in cpr5-2 mutant plants.
We next wanted to address whether resistance genemediated resistance was altered, or possibly enhanced, by the presence of the cpr5-2 mutation. Our finding that the cpr5-2 resistance phenotype was expressed both in plants carrying the rps2 mutation and in plants with a functional RPS2 gene (Table 1) indicates that the cpr5-2 mutation does not behave as an allele-specific suppressor mutation. Further, the generation of homozygous cpr5-2 RPS2 lines facilitated the investigation of any possible effects that the cpr5-2 mutation may have on RPS2-mediated disease resistance.
We monitored the activities of RPS2, as well as two other resistance genes, by assaying for both expression of the HR and restriction of pathogen growth in cpr5-2 RPS2 plants. Wild-type Col-0 plants carry functional RPS2, RPM1, and RPS5 genes and exhibited visible macroscopic tissue collapse indicative of an HR within 20 h after inoculation with high doses of Pst DC3000 expressing avrRpt2, avrRpm1, or avrPphB (data not shown; Debener et al. 1991; Kunkel et al. 1993; Simonich and Innes 1995) . cpr5-2 RPS2 plants also exhibited clear HRs when inoculated with these strains (data not shown). The timing of the HRs observed in these plants was the same as that observed in wild-type Col-0. However, the degree of tissue collapse was reduced by varying degrees in all three interactions (data not shown). Neither cpr5-2 RPS2 plants inoculated with Pst DC3000 nor cpr5-2 rps2 plants inoculated with Pst DC3000 or Pst DC3000 (avrRpt2) exhibited an HR. These results indicate that, as in wild-type plants, the HR in cpr5-2 plants is dependent on the presence of both the bacterial avr gene and the corresponding resistance gene. Further, the absence of an HR in cpr5-2 plants inoculated with Pst DC3000 suggests that enhanced resistance conferred by cpr5-2 is independent of the elicitation of an HR.
Additional evidence that resistance gene-mediated resistance is functional in the context of cpr5-2 stems from the finding that in cpr5-2 RPS2 plants growth of Pst DC3000 expressing avrRpt2 is 50-to 100-fold lower than that observed in cpr5-2 rps2 plants ( Fig. 2A) . These results indicate that in the cpr5-2 mutant background RPS2-mediated resistance is functional and confers additional resistance to Pst DC3000 (avrRpt2). However, given the recent finding that avrRpt2 acts as a virulence factor by promoting pathogen growth in plants lacking a functional RPS2 gene (A. P. Kloek, M. Lim, and B. N. Kunkel, unpublished results), we were concerned that the difference in growth of Pst DC3000 (avrRpt2) in cpr5-2 rps2 and cpr5-2 RPS2 plants might be enhanced by the avrRpt2 virulence activity. Thus, we also assayed RPS2 function by comparing the growth of Pst DC3000 and Pst DC3000 (avrRpt2) in cpr5-2 RPS2 plants. As is shown in Figure 2B , growth of Pst DC3000 in cpr5-2 RPS2 plants is 100-fold lower than in wild-type plants. The growth of Pst DC3000 (avrRpt2) in cpr5-2 RPS2 plants is reduced an additional fourto 10-fold ( Fig. 2B ; and data not shown), confirming that avrRpt2/RPS2-mediated resistance is functional in cpr5-2 plants. In contrast to the experiments summarized in Figure  2A , a cumulative effect of resistance mediated by cpr5-2 and by RPS2 was not reproducibly detectable in these experiments ( Fig. 2B; and data not shown) .
RPM-and RPS5-mediated resistances are also functional in the presence of the cpr5-2 mutation. The growth of Pst DC3000 (avrRpm1), Pst DC3000 (avrB), and Pst DC3000 (avrPphB) was significantly lower than the growth observed for Pst DC3000 in cpr5-2 plants ( Fig. 2C ; and data not shown). In these interactions resistance gene-mediated resistance was very effective in restricting pathogen growth (data not shown), and thus any additional resistance conferred by cpr5-2 was not detected in these experiments.
Defense-related PR genes are expressed in cpr5-2 in the absence of pathogens.
The enhanced resistance and lesion-mimic phenotypes of cpr5-2 are reminiscent of the acd2 and lsd mutants described previously (Dietrich et al. 1994; Greenberg et al. 1994; Weyman et al. 1995) . In these mutants enhanced resistance is correlated not only with the spontaneous appearance of necrotic lesions, but also with elevated defense-related gene expression. To determine whether this was also the case for cpr5-2 we monitored PR gene expression in uninfected plants by RNA blot analysis. As is shown in Figure 5 , the level of expression of two PR genes, PR-1 and BGL2, was undetectable in leaves of mature, uninoculated wild-type Col-0 (CPR5 RPS2) and CPR5 rps2 plants. However, both genes were expressed at elevated levels in leaves of mature, uninoculated cpr5-2 rps2 plants grown under the same conditions (Fig. 5A) . The level of PR gene expression was higher in leaves exhibiting lesions than in leaves without lesions harvested from the Other markers tested that showed no linkage to cpr5-2: GapB, nga111, nga128, UFO, and PVV4 (chromosome 1); Gl1 and nga172 (chromosome 3); PG11(chromosome 4); nga151 and gl3 (chromosome 5). b Data obtained from F 2 seedlings from the cross between rps2 cpr5-2 (Col-0) and gl3 (La-er) c Three-factor analysis indicates that cpr5-2 maps between g2368 and m555. 5 . Expression of PR-1 and BGL2 in uninoculated cpr5-2 plants. A, Total RNA was extracted from mature plants grown in soil and subjected to RNA blot analysis. Lesion-positive (+) and lesion-negative (-) leaves were sampled from the same cpr5-2 plants and RNA was prepared separately for each sample. B, Total RNA was extracted at indicated times (days post germination; dpg) from CPR5 rps2 and cpr5-2 rps2 seedlings grown axenically on Murashige and Skoog (MS) medium. Approximately 2 µg of RNA was loaded for each sample. Blots were first probed with PR-1 and BGL2, followed by hybridization with an rDNA probe as a loading control.
same plant. Elevated PR gene expression was also detected in cpr5-2 plants grown axenically on Murashige and Skoog (MS) agar plates (Fig. 5B) . To determine whether PR gene expression was constitutive, or alternatively whether it was induced during seedling development, we grew cpr5-2 rps2 mutant plants in axenic culture, and harvested seedlings at 1, 2, 3, and 4 weeks after germination. The seedlings were examined through a dissecting scope to determine whether visible lesions were present, and then assayed for PR-1 gene expression by RNA gel blot analysis. PR-1 RNA was not detectable in 7-day-old cpr5-2 seedlings but then was strongly induced by 15 days after germination (Fig. 5B) . Macroscopic lesions did not appear until 21 days after germination. These results indicate that both induction of PR-1 gene expression and lesion development in cpr5-2 rps2 plants are developmentally regulated and occur in the absence of pathogens or other microorganisms.
We also investigated whether enhanced disease resistance and elevated levels of PR gene expression were dependent on SA by analyzing progeny from a cross between cpr5-2 rps2 plants and an A. thaliana transgenic line carrying the bacterial salicylate hydroxylase gene (nahG; Bowling et al. 1994) . We found that nahG is epistatic to cpr5-2 with respect to both enhanced resistance and elevated PR gene expression (data not shown), indicating that cpr5-2 activates the defense response signaling pathway at a point upstream of SA.
Pathogen recognition induces PR-1 gene expression in cpr5-2 mutant plants.
To determine whether the cpr5-2 mutation also affects pathogen-induced defense gene expression we infected cpr5-2 RPS2 plants with Pst DC3000 expressing either avrRpt2, avrRpm1, avrB, or avrPphB and assayed for PR-1 gene expression at various time points after infection. As summarized in Figure 6A , PR-1 expression was not detectable at early points in the time course in CPR5 RPS2 plants, but then was strongly induced between 6 and 12 h after infection with Pst DC3000 (avrRpt2). This pattern of PR-1 induction is typical of RPS2/avrRpt2-dependent defense responses (Reuber and Ausubel 1996) . PR-1 gene expression, which was slightly elevated in uninfected cpr5-2 plants (Fig. 5A ) and in infected cpr5-2 plants at early time points, was also strongly induced between 6 and 12 h after infection, but reached significantly higher levels than was observed in wild-type plants (Fig. 6A) . Interestingly, the elevated basal level of PR-1 gene expression in cpr5-2 RPS2 plants did not significantly alter the timing of avrRpt2/RPS2-mediated activation of PR-1. We observed this significant enhancement of avrRpt2-induced PR-1 expression in four separate experiments. This finding is consistent with the observation that cpr5-2 RPS2 plants exhibited an HR with normal kinetics when infected with Pst DC3000 (avrRpt2), and may account for the additional reduction of pathogen growth observed in cpr5-2 RPS2 mutants infected with Pst DC3000 (avrRpt2) (Fig. 2A) .
We did not detect significant induction of PR-1 in either wild-type or cpr5-2 plants infected with Pst DC3000 expressing avrRpm1 or avrB (Fig. 6A) . This is consistent with previous reports that PR-1 is not induced upon infection with P. syringae expressing avrRpm1 (Reuber and Ausubel 1996) . Thus, to assess RPM1-dependent activation of gene expression, we monitored induction of ELI3, a gene that is rapidly and strongly induced during RPM1/avrRpm1-mediated resistance responses (Kiedrowski et al. 1992; Reuber and Ausubel 1996) . ELI3 was rapidly induced in wild-type plants after infection with Pst DC3000 (avrRpt2), Pst DC3000 (avrRpm1), 5 CFU/ml of Pst DC3000, Pst DC3000 (avrRpt2), Pst DC3000 (avrRpm1), or Pst DC3000 (avrB). PR-1 and ELI3 hybridization signals were quantitated and normalized to signals obtained for the 28S rDNA. Similar results were obtained in a second, independent experiment. and Pst DC3000 (avrB) (Fig. 6B) . Interestingly, expression of ELI3 in response to these strains was not enhanced in cpr5-2 plants. The reduction of ELI3 expression in response to Pst DC3000 and Pst DC3000 (avrRpt2) in cpr5-2 plants was not consistently observed. We found the pattern of induction of PR-1 and ELI3 in response to Pst DC3000 (avrPphB) to be variable (data not shown), and thus we could not draw any meaningful conclusions from these experiments. The results from these experiments indicate that the cpr5-2 mutation enhances the expression of PR-1 in response to RPS2-mediated pathogen recognition, but does not effect ELI3 expression activated by the RPM1 signaling pathway.
DISCUSSION
Identification of a mutant with enhanced resistance to P. syringae.
We have isolated a new mutant allele of CPR5 in a screen for second-site mutations that restore resistance of an rps2 mutant line to Pst DC3000 expressing avrRpt2. The finding that cpr5-2 plants were also resistant to Pst DC3000 not expressing avrRpt2 (Figs. 1 and 2) indicates that resistance in this mutant is independent of RPS2-mediated pathogen recognition. Rather, resistance in cpr5-2 appears to be due to the activation of defense responses in the absence of pathogen recognition.
cpr5-2 mutants express defense responses in the absence of pathogen infection.
cpr5-2 mutant plants exhibited two additional phenotypes indicative of "de-regulated" expression of defense responses: spontaneous development of necrotic lesions and expression of PR genes in the absence of pathogens. Defense-related genes, such as the PR genes, are not expressed at high levels in uninfected wild-type A. thaliana plants. Rather, expression of these genes is induced after pathogen infection ( Fig. 6 ; Ryals et al. 1996) . In contrast, cpr5-2 mutant plants expressed elevated levels of the defense-related genes PR-1 and BGL2 in the absence of pathogen infection (Fig. 5A) . Expression of these genes was highest in leaves exhibiting visible necrotic lesions, but was also detectable at lower levels in leaves without macroscopic lesions. These results are consistent with the findings of Bowling et al. (1997) for cpr5-1, and suggest that lesion formation in cpr5 plants results in activation of both localized and systemic induction of systemic acquired resistance (SAR) gene expression, and thus disease resistance. This hypothesis is supported by the fact that cpr5-1 mutant plants also exhibit elevated levels of SA (Bowling et al. 1997) .
The cpr5-2 phenotypes are reminiscent of the phenotypes of acd2 and lsd mutants, where lesion formation leads to induction of PR gene expression and SAR (Dietrich et al. 1994; Greenberg et al. 1994; Weyman et al. 1995) . Surprisingly, we found that in axenically grown cpr5-2 mutant seedlings, PR-1 gene expression preceded the appearance of visible lesions (Fig. 5) . One possible explanation for this observation is that microscopic lesions were present prior to induction of PR-1 expression in cpr5-2 seedlings grown under these conditions. Alternatively, a signal that induces both lesion formation and PR-1 gene expression may have been present at between 1 and 2 weeks of age in these seedlings, but the environmental conditions present in axenic plant culture caused a delay in lesion formation.
CPR5 is a novel locus involved in disease resistance and trichome development.
One of the most intriguing aspects of the cpr5-2 mutation is that it also affects trichome development. cpr5-2 trichomes are shorter and have fewer branches than those present on wild-type plants (Fig. 4) . Our genetic analysis of cpr5-2 suggests that enhanced disease resistance, lesion development, and the unique trichome defect are conferred by a single, recessive mutation that maps to the lower arm of chromosome 5. The fact that the cpr5-1 mutant also has a similar trichome defect (Bowling et al. 1997 ) lends support to our conclusion that the trichome phenotype can be attributed to a mutation at the CPR5 locus. The CPR5 locus is novel in that it is both important in disease resistance signal transduction and required for normal trichome development.
RPS2, RPM1
and RPS5-mediated defense responses are functional in cpr5-2 plants.
Resistance gene-mediated pathogen recognition is functional in the cpr5-2 mutant background. This conclusion is supported by results from three different assays for resistance gene function. First, cpr5-2 plants exhibited HRs when inoculated with high levels of Pst DC3000 expressing avrRpt2, avrRpm1, or avrPphB. Second, avr gene-mediated restriction of pathogen growth of Pst DC3000 expressing avrRpt2, avrRpm1, avrB, or avrPphB was observed in cpr5-2 mutant plants (Fig. 2) . Third, resistance gene-mediated induction of defense gene expression was induced in cpr5-2 plants after infection with Pst DC3000 expressing these avr genes (Fig. 6) . These results indicate that the cpr5-2 mutation does not interfere with resistance gene-mediated signal transduction.
In fact, the cpr5-2 mutation enhances RPS2-mediated signaling. In cpr5-2 plants infected with Pst DC3000 (avrRpt2), induction of PR-1 expression was significantly higher than in wild-type plants (Fig. 6) . Interestingly, this stimulatory effect of cpr5-2 appears to be specific for the RPS2 signaling pathway, as RPS5 and RPM1-mediated induction of defense genes was not enhanced in the mutant. This result is not surprising given the finding that RPS2 and RPM1 activate different signal transduction pathways leading to defense-related gene expression and resistance (Reuber and Ausubel 1996; Ritter and Dangl 1996) . It is entirely possible that different resistance signaling pathways are regulated in different ways, and that the cpr5-2 mutation affects only a subset of these.
Although RPS2-and cpr5-2-mediated activation of defense responses is cumulative at the level of PR-1 expression, it is difficult to detect enhanced resistance at the level of restriction of pathogen growth. This is presumably due to the fact that resistance gene-mediated defense responses are very effective at limiting pathogen growth, thus masking any additional resistance conferred by cpr5-2. However, we were able to measure a significant cumulative resistance effect in the context of plants carrying an rps2 mutation, in which growth of Pst DC3000 is significantly enhanced by the presence of the avrRpt2 gene ( Fig. 2A) . In this case, the cumulative effect of RPS2 and cpr5-2-mediated defense responses can be monitored in pathogen growth assays.
Possible roles for CPR5 in disease resistance signaling pathways.
The results of our analysis of cpr5-2 agree with those reported for cpr5-1 by Bowling et al. (1997) . Consistent with their model for the role of CPR5 in defense, we propose that cpr5-2 affects an early step in the defense response signaling pathway, upstream of SA, and presumably downstream of pathogen recognition. However, our analysis of the interactions between cpr5-2 and several different resistance gene signaling pathways provides additional information that can be incorporated into a model for how CPR5 may be regulating disease resistance.
The cpr5-2 mutant belongs to the "initiation class" of cell death mutants, which Dangl et al. (1996) define as mutants that "stochastically form lesions of determinate size at inappropriate locations." In this class of mutants it is proposed that the HR signaling pathway and, presumably, the defense response pathway are inappropriately regulated. Based on this hypothesis we envision that the wild-type CPR5 gene product normally acts as a negative regulator of one or more branches of the pathogen response signaling cascade, preventing inappropriate flux through the pathway. Mutations at CPR5 would either partially or entirely remove this level of control, resulting in sensitization or inappropriate activation of the pathway. The phenotype of the cpr5-2 mutant is consistent with this model, as lesion development and the expression of PR genes are uncoupled from the normal induction by pathogen recognition.
In the case of the cpr5-2 mutant, however, the resistance signaling pathways are still capable of responding to positive inputs such as pathogen recognition mediated by the resistance genes RPS2, RPM1, and RPS5. Interestingly, cpr5-2 appears to specifically potentiate signaling through the RPS2 pathway, as PR-1 expression in response to Pst DC3000 (avrRpt2) is significantly enhanced in the mutant. This finding suggests that CPR5 impinges on RPS2 signaling, but does not directly modulate the RPM1 pathway.
An alternative hypothesis is that the cpr5-2 mutation gives rise to an alteration in cellular metabolism that indirectly results in abnormal trichome development, lesion formation, elevated SA levels, expression of PR genes, and the resulting resistance. In this scenario, elevated levels of SA could potentiate enhanced signaling through the RPS2 pathway (Shirasu et al. 1997 ). Thus, cpr5-2 could be a mutation in a gene not normally involved in disease resistance or trichome development. A third possibility is that CPR5 may be required for the normal function of a cellular component, such as the plant cell wall, that plays an important role in both disease resistance signaling and trichome development.
The molecular isolation and further characterization of CPR5 should contribute to our understanding of both pathogen resistance and trichome development, and is likely to lead to important insights into how two seemingly separate processes may be governed by a shared regulatory component.
MATERIALS AND METHODS
Bacterial strains and plasmids.
The bacterial pathogen strains Pseudomonas syringae pv. tomato (Pst) DC3000, Pst 3435, P. syringae pv. maculicola m4, and the avrRpt2, avrRpm1, avrB, and avrPphB avirulence genes, have been described previously (Staskawicz et al. 1987; Debener et al. 1991; Jenner et al. 1991; Whalen et al. 1991; Innes et al. 1993; Kunkel et al. 1993; Ritter and Dangl 1995) . P. syringae strains were cultured at 28°C in King's B medium (King et al. 1954 ) containing 50 µg of rifampicin per ml plus appropriate antibiotics required for plasmid maintenance. The avrRpt2 gene was introduced into these P. syringae strains on plasmids pABL18, pLH12, or pV288 (Whalen et al. 1991; Kunkel et al. 1993) , and the avrRpm1, avrB, and avrPphB genes were introduced on plasmids K48 (Debener et al. 1991) , pPSG0002 (Staskawicz et al. 1987) , or pPPY424 (Fillingham et al. 1992) , respectively. P. syringae strains not expressing avr genes carried control plasmids pLAFR3 or pVSP61 (vectors without insert).
Plant material, growth conditions, and inoculation procedures.
The susceptible rps2-201C mutant used in this work was described previously ). The nahG transgenic line ) and the cpr5-1 mutant (Bowling et al. 1997) were obtained from Scott Bowling and Xinnian Dong (Duke University). A. thaliana plants were grown from seed in growth chambers under an 8-h photoperiod at 24°C. Mass inoculation of plants was carried out by dipping entire leaf rosettes of 3-to 5-week-old plants into bacterial suspensions of 2 to 4 × 10 8 CFU/ml containing the surfactant Silwet L-77 as described in Kunkel et al. (1993) . Pipette infiltrations to assay for the HR were carried out with Pst strains suspended in 10 mM MgCl 2 to a density of approximately 2 × 10 7 CFU/ml . Leaves were scored for tissue collapse approximately 20 h after inoculation. Bacterial growth within leaf tissue was monitored as described by Whalen et al. (1991) .
Mutagenesis and isolation of mutants.
A genetically marked line of rps2-201C carrying a tightly linked molecular marker, PG11, was chosen for the mutant screen to facilitate verification of true suppressor mutants. PG11, which maps within 0.5 cM of RPS2 (Bent et al. 1994) , was used both to confirm that the suppressor mutants were derived from the originally marked rps2-201C mutant line and to follow inheritance of the rps2-201C allele in subsequent crosses. The rps2-201C marked line was derived from an F 2 individual from a cross between the rps2-201C mutant (Col-0 background) and the Nossen (No-0) ecotype that carried a crossover between the mutant rps2 locus and PG11.
Seeds from the marked rps2-201C line were mutagenized by soaking them for 8 h at room temperature in 30 mM EMS. Lots of approximately 30 M 1 seeds were planted and harvested separately to obtain independent populations of M 2 seed. Approximately 2,000 M 2 seeds from each of 10 lots were screened by the L-77 dip-inoculation procedure .
The cpr5-2 RPS2 plants used in our experiments were from homozygous F 3 cpr5-2 RPS2 families derived from a second backcross of cpr5-2 rps2 to CPR5 RPS2 (wild-type Col-0). Families homozygous for the wild-type RPS2 allele were identified by polymerase chain reaction screening with the closely linked PG11 marker.
Genetic analysis and mapping.
The cpr5-2 rps2 mutant was crossed to both CPR5 rps2-201C and wild-type Col-0 to determine the genetic basis of resistance. Allelism tests were carried out by crossing to gl3 (La-er background; Koornneef et al. 1982 ) and cpr5-1 (Bowling et al. 1997) . The F 1 progeny from the cross to cpr5-1 retained the trichome, disease lesion mimic, and enhanced resistance phenotypes characteristic of the mutants, indicating that cpr5-2 and cpr5-1 are allelic. cpr5-2 was also crossed to a transgenic La-er line carrying the nahG gene . As the dominant nahG gene renders plants very susceptible to P. syringae , the F 1 progeny from this cross were not assayed for their resistance phenotype. The F 1 plants were allowed to self-pollinate, and the resulting F 2 progeny were scored for their disease lesion mimic and trichome phenotypes. Tissue was then harvested from individuals with cpr5-2 lesion-mimic and trichome phenotypes for RNA isolation and gel blot analysis to monitor expression of nahG, PR-1, and BGL2. F 2 progeny from both cpr5-2 and wild-type phenotypic classes were then inoculated with Pst DC3000 to assay their resistance phenotypes.
Restriction fragment length polymorphism (RFLP) linkage analysis with codominant cleaved amplified polymorphic DNA sequences (CAPS; Konieczny and Ausubel 1993) and simple sequence length polymorphism (SSLP; Bell and Ecker 1994) markers was performed with progeny from the cross between cpr5-2 (in a Col-0/No-0 hybrid background) and gl3 (La-er background). Plant genomic DNA was isolated from leaf tissue of F 2 plants according to the procedure of Tai and Tanksley (1990) with modifications as described in .
Scanning electron microscopy.
Samples fixed in FAA (3.7% formaldehyde, 50% ethanol, 5% acetic acid) were prepared for scanning electron microscopy by standard methods (Irish and Sussex 1990) .
RNA isolation and analysis.
Total RNA was isolated from A. thaliana leaf tissue with the RNeasy Plant RNA isolation kit (Qiagen, Valencia, CA). RNA gel blot analysis was carried out according to Sambrook et al. (1989) . Hybridization probes were prepared by randomprimer DNA synthesis (Sambrook et al. 1989) . The following DNA probes were used: A. thaliana PR-1 cDNA obtained from Ciba-Geigy (Uknes et al. 1992) ; A. thaliana BGL2 cDNA (Dong et al. 1991) ; A. thaliana ELI3 cDNA (Kiedrowski et al. 1992) ; and nahG . As a loading standard we used a 3.7-kb EcoRI fragment from the 10-kb genomic region carrying A. thaliana rRNA genes (Vongs et al. 1993 ). This probe was kindly provided by Eric Richards (Washington University).
The RNA blots were analyzed with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). The data summarized in Figure 6 were obtained by volume integration of the hybridization signals obtained with the PR-1 or ELI3 probes followed by normalization to the hybridization signals obtained with the rDNA probe.
